AQR Arbitrage’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

AQR Arbitrage’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,190,437	Closed	-$57.2M	–	630
2020 Q1	$57.2M	Sell	1,190,437 -716,226	-38%	-$33.3M	1.91%	6
2019 Q4	$89.5M	Buy	+1,906,663	New	+$84.3M	1.51%	17

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

AQR Arbitrage's RARX Position: Q2 2020 in Review

AQR Arbitrage sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 1,190,437 shares — an estimated $57.2M sold.

AQR Arbitrage first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $89.5M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

AQR Arbitrage reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
AQR Arbitrage sold 1,190,437 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $57.2M.
AQR Arbitrage first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
AQR Arbitrage's Ra Pharmaceuticals, Inc. Common Stock position peaked at $89.5M in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on AQR Arbitrage's 13F filing for Q2 2020, filed 17 Aug 2020.